Tissue-derived tissugenic implants, and methods of fabricating and using same
US8834928B1 · kind B1 · utility
50Cited by
93References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2013 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Jul 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/90
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The disclosure provides implants containing a plurality of particles containing at least one population of viable tissuegenic cells adherent to and resident in the growth-conductive matrix or at least viable population of tissuegenic cells caused to be in contact with the growth-conductive matrix; methods to fabricate implants; methods of fabricating the implants; and use of the implants in tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.